Lilly Bamlanivimab Antibody Playbook
This antibody playbook provides information for state, territorial and local public health programs to plan and operationalize a bamlanivimab antibody response to COVID-19. The sections of this document cover specific areas of COVID-19 antibody program planning and implementation, as well as links to resources to assist with those efforts.
Related Content
Flipping the Script on Medication Errors
CHA Submits Statement for the Record for Drug Shortages Hearing
CHA Letter to Senate HELP Committee on Markup of PAHPA Reauthorization Legislation
Flipping the Script on Medication Errors
Pharmacy teams are utilizing innovative approaches to prevent adverse drug effects.
CHA Submits Statement for the Record for Drug Shortages Hearing
Children's Hospital Association submitted a statement for a legislative hearing to highlight children’s needs when strengthening the pediatric drug supply chain.
CHA Letter to Senate HELP Committee on Markup of PAHPA Reauthorization Legislation
The letter urges lawmakers to prioritize children’s physical and mental health needs in its markup of the Pandemic and All-Hazards Preparedness and Response Act (PAHPA).
